These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 19147071)
41. Autotransplants in acute leukaemia. Gale RP; Horowitz MM; Butturini A Br J Haematol; 1991 May; 78(1):135-7. PubMed ID: 2043473 [TBL] [Abstract][Full Text] [Related]
42. Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). Burke MJ; Cao Q; Trotz B; Weigel B; Kumar A; Smith A; Verneris MR Pediatr Blood Cancer; 2009 Dec; 53(7):1289-94. PubMed ID: 19731318 [TBL] [Abstract][Full Text] [Related]
43. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in adults. Asbmt Position Statement Biol Blood Marrow Transplant; 2008 Feb; 14(2):135-6. PubMed ID: 18215776 [No Abstract] [Full Text] [Related]
44. Auto-SCT for AML in second remission: CALGB study 9620. Linker CA; Owzar K; Powell B; Hurd D; Damon LE; Archer LE; Larson RA; Bone Marrow Transplant; 2009 Sep; 44(6):353-9. PubMed ID: 19289999 [TBL] [Abstract][Full Text] [Related]
45. Concepts underlying autotransplants for cancer. Gale RP; Butturini A Wien Med Wochenschr; 1995; 145(2-3):24. PubMed ID: 7762247 [TBL] [Abstract][Full Text] [Related]
46. Resolution of Behcet's disease after non-myeloablative allogeneic stem cell transplant for acute myeloid leukaemia. Lim SH; Hulsey M; Esler WV Rheumatology (Oxford); 2009 Jan; 48(1):88-9. PubMed ID: 18987011 [No Abstract] [Full Text] [Related]
47. [Relapsed acute myeloid leukemia with Down syndrome showing long disease-free survival after bone marrow transplantation]. Daifu T; Kato I; Matubara H; Abe D; Uryu K; Tokumasu M; Umeda K; Watanabe K; Izawa K; Asai K; Nakahata T; Adachi S Rinsho Ketsueki; 2009 Feb; 50(2):73-7. PubMed ID: 19265297 [TBL] [Abstract][Full Text] [Related]
49. Combined bone marrow and peripheral blood progenitor cell autografts for patients with poor mobilization. Sinitsyn Y; Malone A; Mandeli J; Grosskreutz C; Osman K; Scigliano E; Shi P; Isola L Cytotherapy; 2009; 11(4):457-63. PubMed ID: 19499401 [TBL] [Abstract][Full Text] [Related]
50. IPSS poor-risk karyotype as a predictor of outcome for patients with myelodysplastic syndrome following myeloablative stem cell transplantation. Nevill TJ; Shepherd JD; Sutherland HJ; Abou Mourad YR; Lavoie JC; Barnett MJ; Nantel SH; Toze CL; Hogge DE; Forrest DL; Song KW; Power MM; Nitta JY; Dai Y; Smith CA Biol Blood Marrow Transplant; 2009 Feb; 15(2):205-13. PubMed ID: 19167680 [TBL] [Abstract][Full Text] [Related]
51. The role of registries in facilitating clinical research in BMT: examples from the Center for International Blood and Marrow Transplant Research. Horowitz M Bone Marrow Transplant; 2008 Aug; 42 Suppl 1():S1-S2. PubMed ID: 18724277 [TBL] [Abstract][Full Text] [Related]
52. Should persons with acute myeloid leukemia have a transplant in first remission? Gale RP; Wiernik PH; Lazarus HM Leukemia; 2014 Oct; 28(10):1949-52. PubMed ID: 24727674 [TBL] [Abstract][Full Text] [Related]
53. Comparison of clinical outcomes of patients with relapsed acute promyelocytic leukemia induced with arsenic trioxide and consolidated with either an autologous stem cell transplant or an arsenic trioxide-based regimen. Thirugnanam R; George B; Chendamarai E; Lakshmi KM; Balasubramanian P; Viswabandya A; Srivastava A; Chandy M; Mathews V Biol Blood Marrow Transplant; 2009 Nov; 15(11):1479-84. PubMed ID: 19822309 [TBL] [Abstract][Full Text] [Related]
54. The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of acute myeloid leukemia in children. Executive Committee, American Society for Blood and Marrow Transplantation Biol Blood Marrow Transplant; 2007 Apr; 13(4):500-1. PubMed ID: 17382259 [No Abstract] [Full Text] [Related]
55. Low-dose total body irradiation-based regimens as a preparative regimen for allogeneic haematopoietic cell transplantation in acute myelogenous leukaemia. Al-Ali H; Cross M; Lange T; Freund M; Dölken G; Niederwieser D Curr Opin Oncol; 2009 Jun; 21 Suppl 1():S17-22. PubMed ID: 19561407 [TBL] [Abstract][Full Text] [Related]
56. Is consolidation chemotherapy necessary before non-myeloablative transplantation in AML? Hashmi S; Becker M Leuk Res; 2011 Jul; 35(7):841-3. PubMed ID: 21481455 [No Abstract] [Full Text] [Related]
57. The latest treatment advances for acute myelogenous leukemia. Colvin GA; Elfenbein GJ Med Health R I; 2003 Aug; 86(8):243-6. PubMed ID: 14582219 [TBL] [Abstract][Full Text] [Related]
59. Is transplantation in first remission AML more effective than in advanced leukemia? Gale RP; Butturini A Leuk Res; 1989; 13(12):1035-8. PubMed ID: 2615462 [TBL] [Abstract][Full Text] [Related]
60. Autologous hematopoietic stem cell transplantation in adult acute lymphoblastic leukemia: still not out of fashion. Doubek M; Folber F; Koristek Z; Brychtova Y; Krejci M; Tomiska M; Navratil M; Mikulasova P; Mayer J Ann Hematol; 2009 Sep; 88(9):881-7. PubMed ID: 19172272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]